Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs

Human Psychopharmacology
David Wheatley

Abstract

A triple-blind (investigator, patient, statistician), randomized, placebo-controlled, trial of Ginkgo biloba 240 mg daily was carried out. Following a 1-week control, it was given to 24 patients with sexual impairment due to antidepressant drugs. Efficacy analysis was carried out on eight males and five females on placebo and six males and five females on Ginkgo, completing the full 12 weeks of treatment. Not included were three subjects who dropped out after 6 weeks. A validated, sex (gender)-orientated questionnaire was recorded at - 1, 0, 1, 3, 6, 9 and 12 weeks, and a non-blind follow-up for a further 6-weeks on Ginkgo. Hamilton anxiety and depression ratings were made at 0, 6 and 12 weeks and simple global assessments of alertness and memory. There were some spectacular individual responses in both groups, but no statistically significant differences, and no differences in side-effects.

References

Jun 5, 1998·Journal of Sex & Marital Therapy·A J Cohen, B Bartlik
Mar 19, 1999·Journal of Sex & Marital Therapy·R Balon
Apr 28, 2000·The American Journal of Psychiatry·A K AshtonP S Masand
Jul 24, 2001·The International Journal of Neuropsychopharmacology·C StoughP J Nathan
Oct 31, 2002·Human Psychopharmacology·Albert Michael, Veronica O'Keane

❮ Previous
Next ❯

Citations

Nov 11, 2006·Current Psychiatry Reports·Matthew J Taylor
Aug 26, 2014·Expert Opinion on Drug Safety·Anita H ClaytonAlexandra Elizabeth Schuck
Apr 21, 2012·Climacteric : the Journal of the International Menopause Society·E FooladiS R Davis
May 6, 2016·Annals of Medicine·Richard L LinLynn A Drake
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Ronald Tamler, Jeffrey I Mechanick
Sep 6, 2006·International Journal of Impotence Research·S Seidman
Apr 14, 2020·Asia-Pacific Journal of Ophthalmology·Margarita LabkovichRobert Ritch
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Matthew J TaylorKeith Hawton
Apr 4, 2021·Pharmacy : Journal of Pharmacy, Education and Practice·Nicole E Cieri-HutchersonTimothy C Hutcherson
Jun 23, 2021·Planta medica·Inés Moragrega, José Luis Ríos
Aug 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nelisiwe Prenate MasukuSogolo Lucky Lebelo
Dec 6, 2020·Sexual Medicine Reviews·Valerie Jia-En SinHwee-Ling Koh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.